Physician profile

Robert J Lynch

Internal Medicine · Martinsburg, WV

NPI 1346357456

$1,927.79

in general payments reported to CMS, 2019-2025

16 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $543.29 2019-2020
Janssen Pharmaceuticals, INC $399.16 2019-2020
Glaxosmithkline, LLC. $243.17 2019-2020
Novo Nordisk INC $210.92 2019-2020
Lilly USA, LLC $140.73 2019-2020
Mylan Specialty L.P. $90.90 2019-2020
Novartis Pharmaceuticals Corporation $56.12 2019-2020
Merck Sharp & Dohme LLC $51.27 2019
Astellas Pharma US INC $40.86 2019-2020
Sanofi-Aventis U.S. LLC $38.33 2019
Amgen INC. $29.97 2019-2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $29.06 2019-2020
Kowa Pharmaceuticals America, INC. $14.89 2020
Boehringer Ingelheim Pharmaceuticals, INC. $13.50 2019
Genentech USA, INC. $13.09 2019
Show all 16 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $12.53 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert J Lynch

$1,927.79

in general payments reported 2019-2025

Years
2019-2020
Top company
Astrazeneca Pharmaceuticals LP

https://glasscript.com/doctor/288218/robert-j-lynch

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.